Anna Trigos
Impact in
-
- Cancer Genomics and Diagnostics
Papers in
-
- Epigenetics and DNA Methylation 4
- Single-cell and spatial transcriptomics 2
- Melanoma and MAPK Pathways 2
- RNA modifications and cancer 2
- Oncology 5
- Cancer Immunotherapy and Biomarkers 3
- Co-authors
- Richard B. Pearson (8 shared papers)David L. Goode (8 shared papers)Anthony T. Papenfuss (4 shared papers)Jian Kang (3 shared papers)Keefe T. Chan (3 shared papers)Elaine Sanij (3 shared papers)Katherine M. Hannan (2 shared papers)Haoran Zhu (2 shared papers)
- Journals
- Journal of Clinical Oncology (2 papers)eLife (2 papers)British Journal of Cancer (1 paper)Nature Communications (1 paper)mSphere (1 paper)
- Partner nations
- AustraliaSpainUnited States
In The Last Decade
Anna Trigos
15 papers receiving 415 citations
Peers
Comparison fields: 5 of 75
- Cancer Research 122
- Aging 12
- Molecular Biology 307
- Cell Biology 60
- Biophysics 19
Countries citing papers authored by Anna Trigos
This map shows the geographic impact of Anna Trigos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Trigos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Trigos more than expected).
Fields of papers citing papers by Anna Trigos
This network shows the impact of papers produced by Anna Trigos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Trigos. The network helps show where Anna Trigos may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Trigos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 136 | |
| 2 | 2018 | 93 | |
| 3 | 2019 | 47 | |
| 4 | 2019 | 44 | |
| 5 | 2023 | 38 | |
| 6 | 2020 | 28 | |
| 7 | 2022 | 24 | |
| 8 | 2023 | 8 | |
| 9 | 2021 | 4 | |
| 10 | 2025 | 2 | |
| 11 | 2024 | 2 | |
| 12 | 2015 | 2 | |
| 13 | 2023 | 1 | |
| 14 | 2020 | 1 | |
| 15 | 2020 | 1 | |
| 16 | 2024 | 0 | |
| 17 | 2023 | 0 |
About Anna Trigos
Anna Trigos is a scholar working on Molecular Biology, Oncology, Cancer Research, Pulmonary and Respiratory Medicine and Immunology, having authored 17 papers that have together received 431 indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Single-cell and spatial transcriptomics (2 papers), Melanoma and MAPK Pathways (2 papers), Ferroptosis and cancer prognosis (2 papers), Cancer Genomics and Diagnostics (2 papers), Prostate Cancer Treatment and Research (2 papers) and RNA modifications and cancer (2 papers). The work is most often cited by research in Cancer Research (122 citations), Aging (12 citations), Molecular Biology (307 citations), Cell Biology (60 citations) and Biophysics (19 citations). Anna Trigos has collaborated with scholars based in Australia, Spain and United States. Frequent co-authors include Richard B. Pearson, David L. Goode, Anthony T. Papenfuss, Jian Kang, Keefe T. Chan, Elaine Sanij, Katherine M. Hannan, Haoran Zhu, Ross D. Hannan and Lassi Paavolainen. Their work appears in journals such as Journal of Clinical Oncology, eLife, British Journal of Cancer, Nature Communications and mSphere.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.